Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dov Shapiro

Pediatrics Lincolnshire, IL Medical Doctor

NPI 1801995634 CMS profile 1276897

430 Milwaukee Ave, Lincolnshire, IL 60069

Open in the dashboard

General payments

$44,974

418 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Dov Shapiro of Lincolnshire, IL is reported in the CMS Open Payments database as having received $44,974 across 418 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,516 62
2024 General $13,752 99
2023 General $14,440 79
2022 General $12,831 78
2021 General $1,745 49
2020 General $120 8
2019 General $571 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dov Shapiro
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Dov Shapiro were reported at $1,516. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Dov Shapiro Pediatrics median Middle half National median
2019 $571 $86 $31–$183 $163
2020 $120 $49 $22–$110 $114
2021 $1,745 $68 $27–$158 $132
2022 $12,831 $77 $30–$173 $149
2023 $14,440 $88 $33–$190 $160
2024 $13,752 $94 $34–$206 $164
2025 $1,516 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Cepheid $38,768 49 payments
  2. Supernus Pharmaceuticals, Inc. $1,174 49 payments
  3. Corium, Inc. $559 43 payments
  4. Seqirus USA Inc $530 40 payments
  5. Ironshore Pharmaceuticals Inc. $461 35 payments
  6. Tris Pharma Inc $428 26 payments
  7. Merck Sharp & Dohme Corporation $366 20 payments
  8. Neos Therapeutics, LP $362 28 payments
  9. Pfizer Inc. $310 15 payments
  10. Takeda Pharmaceuticals U.S.A., Inc. $290 21 payments
  11. Other $1,726 92 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $33,025 32 payments
  2. Food and Beverage $7,146 373 payments
  3. Travel and Lodging $4,803 13 payments
Products named General payments · program years 2019–2025
  1. GeneXpert Devices $37,868 47 payments
  2. GENEXPERT Devices $900 2 payments
  3. QELBREE Psychology $717 37 payments
  4. Azstarys $559 43 payments
  5. Qelbree Viloxazine Hydrochloride $456 12 payments
  6. VYVANSE $312 23 payments
  7. GARDASIL 9 $310 16 payments
  8. VAXELIS $283 14 payments
  9. COTEMPLA XR-ODT $278 23 payments
  10. JORNAY PM $275 23 payments
  11. Other $5,319 298 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

418 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record